Drug Database
Back to search

Germany· DE-A57-41b2833734e85e2a

Eribulin Beta

A eribulin product containing eribulin, registered in Germany by Betapharm Arzneimittel Gmbh. The same ATC class is registered in 18 of our 19 countries.

ATC L01XX41

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedEribulin BetaATCL01XX41REGISTER NO.DE-A57-41b2833734e85e…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about eribulinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Eribulin is registered in 18 of 19 countries.

Countries holding a registration under ATC L01XX41 (eribulin), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 10 of them publish a price we can compare per daily dose
Search eribulin products by name

Eribulin · ATC L01XX41

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Eribulin
Manufacturer
Betapharm Arzneimittel Gmbh
Country
Germany (DE)
ATC code
L01XX41
ATC class
Eribulin
Defined daily dose
0.21 mg, P
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

428 interactions on record for eribulin.

Graded by severity as the source publishes them — 93 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check eribulin against other medicinesHow interaction checks work

Eribulin · interactions on record

428 records

  • 93 severe
  • 331 moderate
  • 4 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eribulin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eribulin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Eribulin Accord, Eribulin Advanz Pharma
  • Belgium · Eribulin Advanz Pharma, Eribulin Eg
  • Bulgaria · Eribulin Ever Pharma, Sclarint
  • Czechia · Erhopana, Eribulin Accord
  • Denmark · Eribulin Accord, Eribulin Ever Pharma
  • Estonia · Eribulin, Eribulin Accord
  • Spain · Eribulina, Eribulina Advanz Pharma
  • Finland · Eribulin, Eribulin Accord
  • France · Eribuline Accord, Eribuline Advanz Pharma
  • United Kingdom (Northern Ireland) · Eribulin Dr. Reddy's Laboratories (Uk), Eribulin Glenmark Pharmaceuticals Europe
  • Greece · Eribulin Ever Pharma
  • Croatia · Eribulin, Eribulin Accord
  • Hungary · Eribulin Advz, Eribulin Ever Pharma
  • Ireland · Eribulin Advanz Pharma, Eribulin Ever Pharma
  • Iceland · Advz, Eribulin Advanz Pharma
  • Italy · Eribulina Advanz Pharma, Eribulina Eg
  • Liechtenstein · Eribulin Baxter, Halaven
  • Lithuania · Eribulin, Eribulin Accord
  • Luxembourg · Eribulin Eg
  • Latvia · Eribulin, Eribulin Advz
  • Malta · Eribulin Tillomed
  • Netherlands · Eribulin Ever Pharma, Eribuline Hikma
  • Norway · Eribulin Accord, Eribulin Advanz Pharma
  • Poland · Eribulin Ever Pharma
  • Portugal · Eribulina Advanz Pharma, Eribulina Cttq
  • Romania · Erhopana, Eribulin Ever Pharma
  • Sweden · Eribulin, Eribulin Accord
  • Slovenia · Eribulin Ever Pharma
  • Slovakia · Eribulin Advz, Eribulin Agmed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0a474895-1ba1-414d-81a4-41107309be48
GET /v1/drugs/0a474895-1ba1-414d-81a4-41107309be48?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intravenous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Eribulin",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about eribulin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console